We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Urine Osmolality Measurement Evaluated on Automated Analyzer

By LabMedica International staff writers
Posted on 06 Oct 2020
Urinalysis is a convenient and non‐invasive screening tool for use in both an outpatient and inpatient setting. More...
Automated flow cytometry‐based urine analyzer is increasingly being used to identify and enumerate cells and particles in urine specimens. It measures electrical conductivity which could be transformed to osmolality.

The osmolality of urine, which indicates the quantity of osmotically active particles, can be estimated by the specific gravity (SG). While the SG correlates with urine osmolality, the direct measurement of urine osmolality is more accurate and is considered the gold standard for determining the hydration status of the body and its ability to concentrate urine.

Laboratory Medical Scientists at the Pusan National University Yangsan Hospital (Yangsan, South Korea) collected 270 random urine samples, also known as spot samples, for analysis that included osmolality testing from May 2018 to July 2018. The precision of urine osmolality measurement by the UF‐5000 (Sysmex Corporation, Kobe, Japan) was evaluated for 20 days and four times a day for two concentrations. The linearity and detection capability were evaluated according to the Clinical and Laboratory Standards Institute guidelines. A comparison analysis between the UF‐5000 and the OsmoPro equipment (Advanced Instruments, Norwood, MA, USA) was performed in the laboratory using random urine samples from patients.

The laboratorians reported that the laboratory‐based coefficient variations were less than 5%. Urine osmolality using the UF‐5000 has a verified linear range (R2 = 0.997). Within the comparison analysis, the mean difference was not large (−7.72%), but each differences were largely dispersed with 95% limits of agreement (LoA) from −70.5 to 55.06%, and the mean absolute difference −28.3 mOsm/kg with 95% LoA from −295.13 to 238.45 mOsm/kg. Cohen's kappa value was 0.54. The mean ± SD osmolality measured by the OsmoPro and UF5000 was 450.33 ± 227.51 mOsm/kg and 421.99 ± 221.53 mOsm/kg, respectively.

The authors concluded that the conductivity‐based measurement of osmolality has reliable precision and linearity within a specific range that includes the reference range. Considering the good accessibility of routine analyzer, UF‐5000 can be used to determine whether the urine osmolality is within the reference or should be measured by freezing depression method. The study was published on September 24, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:
Pusan National University Yangsan Hospital
Sysmex Corporation
Advanced Instruments



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Guardant Health has introduced new applications for Guardant360 Liquid, expanding the test’s capabilities for treatment selection in breast and lung cancers. (Photo courtesy of Guardant Health)

Liquid Biopsy Expands Insights Into Treatment Response and Tumor Alterations

Treatment selection in advanced breast and lung cancers can be challenging when traditional biomarkers are absent and genomic findings alone do not fully clarify which therapies may be effective.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.